47
Views
2
CrossRef citations to date
0
Altmetric
Original Article

T HE E FFECTS OF P REHOSPITAL A DVANCED L IFE S UPPORT D RUG T REATMENT ON P ATIENT I MPROVEMENT AND I N-HOSPITAL U TILIZATION

, , &
Pages 252-260 | Published online: 02 Jul 2009

References

  • Chatterson M, Dunne G, Murray M, et al. The Provincial Base Hospital Advisory Group-Symptom Relief Drug Program. Learner's Manual, Ontario, Canada, 1996.
  • Howell MA, Guly HR. A comparison of glucagon and glucose in pre-hospital hypoglycemia. J Accid Emerg Med. 1997;14:30–2.
  • Vukmir RB, Paris PM, Yealy DM. Glucagon: prehospital thera-py for hypoglycemia. Ann Emerg Med. 1991;20:375–9.
  • Steel JM, Allwinkle J, Moffat R, Carrington DJ. Use of Lucozade and glucagon by ambulance staff for treating hypoglycemia. BMJ. 1992504: 1283–4.
  • McErlean M, Raccio-Robak N, Bartfield JM, Hermes D. Safe out-of-hospital treatment of chest pain without direct medical con-trol. Prehosp Disaster Med. 1996;11:16–9.
  • Wuerz R, Swope G, Meador S, Holliman JC, Roth GS. Safety of prehospital nitrogylcerin. Ann Emerg Med. 1994;23:31–6.
  • Lindebeck GH, Burns DM, Rockwell DD. Out-of-hospital provider use of epinephrine for allergic reactions: pilot pro-gram. Acad Emerg Med. 1995;2:592–6.
  • Barach EM, Nowak RM, Lee TG, Tomlanovich MC. Epinephrine for treatment of anaphylactic shock. JAMA. 1984;251:2118–22.
  • Fortenberry EL Laine J, Shalit M. Use of epinephrine for ana-phylaxis by emergency medical technicians in a wilderness set-ting. Ann Emerg Med. 1995;25:785–7.
  • ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2: 349–60.
  • Antiplatelet Trialists' Collaboration. Collaboration overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81–106.
  • Fergusson RJ, Stewart CM, Wathen CG, Moffat R, Crompton GK. Effectiveness of nebulised salbutamol administered in ambulances to patients with severe acute asthma. Thorax. 1995;50:81–2.
  • Campbell IA, Colman SB, MaoPrescott RJ, Weston CF. Anopen, prospective comparison of beta 2 agonists given via neb-uliser, nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment. Thorax. 199550: 79–80.
  • Lowhagen O, Ekstrom L, Holmberg S, Wennerblom B, Rosenfeldt M. Experience of an emergency mobile asthma treat-ment programme. Resuscitation. 199755: 243–7.
  • Eisen JS, Dubinsky I. Advanced life support vs basic life support field care: an outcome study. Acad Emerg Med. 19985: 592–8.
  • Weiss SJ, Anand P, Ernst AA, Orgeron D, May VVL. Effect of out-of-hospital albuterol inhalation treatments on patient com-fort and morbidity. Ann Emerg Med. 1994;24:873–8.
  • Shuster M, Keller J, Shannon H. Effects of prehospital care on outcome in patients with cardiac illness. Ann Emerg Med. 1995;26:138–45.
  • Wuerz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med. 1992;21:669–74.
  • Adams J, Aldag G, Wolf ord R. Does the level of prehospital care influence the outcome of patients with altered levels of con-sciousness? Prehosp Disaster Med. 1996;11:101–4.
  • Statistics Canada. Profile of Census Tracts. Ottawa: Industry Canada, 1999. 1996 Census of Canada. Catalogue number 95-201-XPB.
  • Keller JL, Shuster M, Rowe BH. Reliability of prehospital rating scales for case severity and status change. Am J Emerg Med. 1993;11:115–21.
  • Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996;27:305–8.
  • Sokal RR, Rohlf JF. Assumptions of analysis of variance. In: Biometry. 3rd. New York: W. H. Freeman and Company, 1995, pp 392–450.
  • Shuster M, Shannon HS. Differential prehospital benefit from paramedic care. Ann Emerg Med. 1994;23:1014–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.